Research

No Applicants //  Limit: 2 // Tickets Available: 2 

Applicant institutions are limited to no more than two pre-applications and two applications as the lead institution.

The DOE SC program in Biological and Environmental Research (BER), through its Bioimaging Research effort, hereby announces its interest in receiving innovative applications to advance fundamental research or use-inspired technologies of new bioimaging or sensing approaches. Fundamental research to enhance spatial and temporal resolution, measurement speed, long-term sample stability, selectivity, sensitivity, or chemical specificity of bioimaging technologies are desirable. Proposed research should demonstrate a comparative advantage over state-of-the-art techniques or identify biological characteristics that cannot currently be measured. Quantumenabled technologies are allowed but not required in this FOA. Applications can be submitted under one of two subtopics: 1) Novel research concepts proceeding through technical validation that are not required to evaluate new biological hypotheses; 2) Innovative experimental prototype research proceeding through hypothesis-driven biological experimentation; proposals submitted under this subtopic are encouraged to coordinate with biological collaborators if domain expertise is not in-house. All applications are expected to describe how, if realized, they would advance biological knowledge of plant and microbial systems relevant to bioeconomy or environmental research in fields of study supported by BER.

Limit: 2* // Tickets Available: 0

• Science & Engineering Track - P. Carini (Environmental Sciences)
• Medical Research Track - M. Cai (Chemistry & Biochemistry)

Please note the internal deadline has been extended to May 8, 2024. 

*UA may submit one concept paper in Physical Sciences and Engineering and one concept paper in Medical Sciences in this cycle.
The selected projects must participate in the concept counseling session with the W.M. Keck Foundation between July 1 and August 15 to determine if they can proceed to the Phase I submission.

The W.M. Keck Foundation Research Program uses a three-step process for this opportunity. The first step is a Concept paper. The Undergraduate Education program is currently not accepting concept papers. The next steps are by the foundation’s invitation. UArizona review criteria reflect previous interactions with the W.M. Keck Foundation. Proposals should focus on basic, fundamental science with broad applications. Grants range from $1 million to $5 million and are typically $2 million or less.

The proposed work should show a significant leap forward rather than an extension of existing work.  

To be considered by Keck, applicants must have a statement from a federal program officer expressing that the project is not a good fit due to risk (rather than technical or theoretical fit) or a decline from a federal program where the summary statement or individual reviews highlight the incredible novelty, but the high-risk nature that makes it difficult to fund at the federal level.

 

The Science and Engineering Research Program seeks to benefit humanity by supporting high-risk/high-impact projects that are distinctive and novel in their approach to intractable problems, push the edge of their field, or question the prevailing paradigm. Past grants have been awarded to support pioneering science and engineering research and the development of promising new technologies, instrumentation, or methodologies. 

The Medical Research Program seeks to advance the frontiers of medicine to benefit humanity by supporting high-risk/high-impact projects that are distinctive and novel in their approach to intractable problems, push the edge of their field, or question the prevailing paradigm. Past grants have supported pioneering biological research, basic research, and the development of promising new technologies. The Keck Foundation does NOT fund work that is clinical, applied, or translational; treatment trials; or research for the sole purpose of drug development. 

Both senior and early career investigators are encouraged to apply. Team approaches, including interdisciplinary teams, are encouraged.

 Limit: 1 // I. Romano (School of Art)

The program continues to focus on stimulating new research in the humanities and its publication by supporting the work of individual scholars doing research or writing. We are, however, introducing changes in eligibility requirements expected to bolster support for new applicants. We are also pleased to announce that we are increasing the award amount to $8000 and expect to maintain similar funding rates as in past years, even as NEH limits submissions to one per institution for those subject to the nomination requirement. The new program guidelines will be posted by June 18, 2024 on our website at: https://www.neh.gov/grants/research/summer-stipends  

Institutions of higher education in the United States and its jurisdictions may each nominate two faculty members per deadline.

• Application available (anticipated): June 18, 2024
• Next deadline (anticipated): September 18, 2024

Due to the competitive nature of this funding program, the internal competition is run based on the anticipated September 18, 2024, deadline.

The National Endowment for the Humanities’ Summer Stipends program aims to stimulate new research in the humanities and its publication. The program works to accomplish this goal by:

• Providing small awards to individuals pursuing advanced research that is of value to humanities scholars, general audiences, or both
• Supporting projects at any stage of development, but especially early-stage research and late-stage writing in which small awards are most effective
• Funding a wide range of individuals, including independent scholars, community college faculty, and non-teaching staff at universities

Summer Stipends support continuous full-time work on a humanities project for a period of two consecutive months.  NEH funds may support recipients’ compensation, travel, and other costs related to the proposed scholarly research.

No applicants // Limit: 1 // Tickets Available: 1

T. Kalin ( Phoenix Children’s Research Institute -Translational Research) Subaward 

Hyundai Hope On Wheels® [“HHOW”] is a 501(c)(3) non-profit organization that joined the fight against childhood cancer in 1998. The organization funds life-saving research and creates awareness for childhood cancer. Since its inception, HHOW has donated more than $225 million to fund pediatric cancer research. 

In 2024, the following categories of research grants for pediatric cancer are available per this RFP: 

• Hope Scholar Grant: $400,000 (two-year award), please see pages 4-5 for details. 

• Young Investigator Grant: $250,000 (two-year award), please see page 6 for details. 

Eligibility to apply for a Hope Scholar or Young Investigator Grant is limited to Children’s Oncology Group (“COG”) member institutions in the U.S. Each eligible institution may submit up to one application per grant category. Applicants will be notified by March 15, 2024, about grant awardees. If selected, the first funding installment is planned for release on December 31, 2024. Approved research projects may begin upon receipt of the initial grant award disbursement. If selected, material conditions for the institution that receives a grant are to agree to all terms and conditions of the grant agreement, and to agree to host a Hyundai Hope On Wheels handprint ceremony at its location or virtually during August or September of 2024. 

No applicants // Limit: 1 // Tickets Available: 1

Hyundai Hope On Wheels® [“HHOW”] is a 501(c)(3) non-profit organization that joined the fight against childhood cancer in 1998. The organization funds life-saving research and creates awareness for childhood cancer. Since its inception, HHOW has donated more than $225 million to fund pediatric cancer research. 

In 2024, the following categories of research grants for pediatric cancer are available per this RFP: 

• Hope Scholar Grant: $400,000 (two-year award), please see pages 4-5 for details. 

• Young Investigator Grant: $250,000 (two-year award), please see page 6 for details. 

Eligibility to apply for a Hope Scholar or Young Investigator Grant is limited to Children’s Oncology Group (“COG”) member institutions in the U.S. Each eligible institution may submit up to one application per grant category. Applicants will be notified by March 15, 2024, about grant awardees. If selected, the first funding installment is planned for release on December 31, 2024. Approved research projects may begin upon receipt of the initial grant award disbursement. If selected, material conditions for the institution that receives a grant are to agree to all terms and conditions of the grant agreement, and to agree to host a Hyundai Hope On Wheels handprint ceremony at its location or virtually during August or September of 2024. 

Limit: 2 // Tickets Available: 1

M. Chertkov (Applied Math)

Applicant institutions are limited to both:
• No more than two pre-applications or applications as the lead institution.
• No more than one pre-application or application for each PI at the applicant institution.

The DOE SC program in Advanced Scientific Computing Research (ASCR) hereby announces its interest in research applications to explore potentially high-impact approaches in the development and use of data reduction techniques and algorithms to facilitate more efficient analysis and use of massive data sets produced by observations, experiments and simulation.

Scientific observations, experiments, and simulations are producing data at rates beyond our capacity to store, analyze, stream, and archive the data in raw form. Of necessity, many research groups have already begun reducing the size of their data sets via techniques such as compression, reduced order models, experiment-specific triggers, filtering, and feature extraction. Once reduced in size, transporting, storing, and analyzing the data is still a considerable challenge – a reality that motivates SC’s Integrated Research Infrastructure (IRI) program [1] and necessitates further innovation in data-reduction methods. These further efforts should continue to increase the level of mathematical rigor in scientific data reduction to ensure that scientifically-relevant constraints on quantities of interest are satisfied, that methods can be integrated into scientific workflows, and that methods are implemented in a manner that inspires trust that the desired information is preserved. Moreover, as the scientific community continues to drive innovation in artificial intelligence (AI), important opportunities to apply AI methods to the challenges of scientific data reduction and apply data-reduction techniques to enable scientific AI, continue to present themselves [2-4].

The drivers for data reduction techniques constitute a broad and diverse set of scientific disciplines that cover every aspect of the DOE scientific mission. An incomplete list includes light sources, accelerators, radio astronomy, cosmology, fusion, climate, materials, combustion, the power grid, and genomics, all of which have either observatories, experimental facilities, or simulation needs that produce unwieldy amounts of raw data. ASCR is interested in algorithms, techniques, and workflows that can reduce the volume of such data, and that have the potential to be broadly applied to more than one application. Applicants who submit a pre-application that focuses on a single science application may be discouraged from submitting a full proposal.

 Limit: 1 // K. Lutrick (Research, Family & Community Medicine) & K. Ellingson (Epidemiology and Biostatistics)

Only one application per institution (normally identified by having a unique entity identifier [UEI] number) is allowed. 

The purpose of this Notice of Funding Opportunity (NOFO) is to establish: 1) a multi-site community-based cohort study that would allow close monitoring of the burden of acute respiratory illness in the community, contributions of various respiratory viruses to this burden, and the impact of vaccination and other interventions on risk of infection and/or severe outcomes, and 2) a case-ascertained household transmission study (or multi-site study) that would support ongoing assessment of transmission dynamics of respiratory viruses of interest and factors (i.e., demographic, clinical, or household-level factors) that may impact transmission.

While hospital-based platforms are key to assessing frequency and risk factors for severe disease, community-based platforms are essential for understanding age-specific incidences of infection, risk factors for infection, socioeconomic burden of infections (such as days of work/school lost), and the clinical spectrum of illness. They are important for characterizing the immune response to infection or reinfection and long-term outcomes, and they are key to understanding the impact of individual- and household-level mitigation factors (including but not limited to vaccination) on all of these measures. This type of network may be especially useful for detecting changes in any of these factors when a new virus or viral variant begins circulating.

Case-ascertained household transmission studies are well-positioned to quickly and efficiently enable us to understand transmission dynamics of respiratory viruses (or sublineages/types of existing viruses that undergo frequent mutation, such as SARS-CoV-2 and influenza) and assess potential mitigation factors. These studies can also be valuable for characterizing viral shedding dynamics and infectiousness. These studies were key during the COVID-19 pandemic to understanding if changes in hospitalization rates were due to changes in transmissibility/infection rates versus changes in severity of illness. They are also great resources for assessing how history of vaccination or prior history of infection effect transmission to close contacts.

This NOFO would build on the lessons learned during the COVID-19 pandemic and establish a consolidated network of community cohorts to monitor a range of respiratory viruses among community members who develop symptoms of acute respiratory illness. Incorporation of multi-pathogen testing will allow us to better understand the relative contribution of various viruses to the overall community burden of respiratory disease now in the post-pandemic setting, and how the clinical spectrum of these illnesses compare, in a setting in which multiple new preventive products are becoming available. This would also support the establishment of a case-ascertained transmission study (or multi-site study) that would be able to assess SARS-CoV-2, Respiratory Syncytial Virus (RSV), and other prioritized respiratory viruses on an ongoing basis.

The combination of these studies will generate much greater visibility on risk factors for infection and the effectiveness of various interventions in reducing infections and viral transmission, factors that are relevant to reducing overall morbidity and mortality related to respiratory viruses. Should a new variant or virus arrive, this platform would be well positioned to further expand testing to better understand potential concerns like proportion symptomatic, timing of transmission, likelihood of asymptomatic transmission and other related questions. Such questions may be key to developing public health guidance should additional mitigation measures become necessary.

Limit: 2 // Tickets Available: 1

G. Sutphin (Molecular and Cellular Biology)

The mission of Breast Cancer Alliance is to improve survival rates and quality of life for those impacted by breast cancer through better prevention, early detection, treatment and cure. To promote these goals, we invest in innovative research, breast surgery fellowships, regional education, dignified support and screening for the underserved.

The research project must be directly related to the field of breast cancer. Areas of relevant research may include but are not limited to: diagnosis, etiology, immunology, genetics and epigenetics, therapies, prevention and clinical studies.

No applicants // Limit: 1 // Tickets Available: 1 

The University of Arizona Cancer Center (UACC) can nominate one application for this funding program.
For more information, please contact: UACC-PreAward.

UACC Limited Submission Information:

The University of Arizona Cancer Center (UACC) can nominate one applicant for the V Foundation Women Scientists Innovation Award for Cancer Research 2024.

Purpose of Award:

The UACC is seeking nominations for the Women Scientists Innovation Award for Cancer Research which supports women cancer researchers and is restricted to adult cancer research. 

Sustaining the careers of women in research and preventing the loss of women from academic careers focused on cancer is paramount to accomplishing the V Foundation’s mission. Women are underrepresented in many STEM fields and this disparity becomes more pronounced further along the career continuum. To make significant progress towards Victory Over Cancer®, we need all voices at the table. The V Foundation’s Women Scientists Innovation Award for Cancer Research helps promote inclusion for women in cancer research while supporting the most cutting-edge proposals.

Applicant Eligibility

Nominee must meet all of the following criteria by the nomination due date:

• Self-identify as a woman
• Nominated by their Cancer Center Director or similar high ranking research official.
• Employed at a non-profit research institution (e.g., 501c3, Section 170).
• See additional criteria for Translational and V Scholar mechanisms listed in corresponding RFA and Supporting Documents.

If you have any question concerning eligibility and details regarding the opportunity, please contact the Grants Team at Grants@v.org in advance of applying.

For any other questions, please contact UACC-PreAward@arizona.edu.

No Applicants  // Limit: 1 proposal per priority area

Applicants may submit multiple applications that uniquely address one or more of these program priority areas. However, applicants may not submit multiple applications addressing the same program priority area. 

This notice announces the availability of funds and solicits applications from eligible entities to advance national policy or systems-level change to reduce indoor air risks and yield measurable environmental and public health outcomes. The EPA has identified and characterized significant risks to public health from indoor environmental contaminants that are commonly found in homes, schools, and offices or commercial non-industrial buildings where Americans spend up to 90 percent of their time. Levels of air pollution indoors are often two to five times higher, and occasionally 100 times higher than outdoor levels. Common indoor air contaminants include:
• Radon
• Environmental asthma triggers (e.g., secondhand smoke; cockroaches and other pests; chemical irritants; dust mites; pet dander; nitrogen dioxide; wood smoke; and mold)
• Pathogens transmitted through the air (e.g., SARS-COV-2, Influenza)
• Particulate matter
• Combustion byproducts
• Volatile organic compounds

Estimates of the economic costs in the US associated with adverse health and productivity effects of poor indoor air quality (IAQ) fall between $13 and $32 billion annually. Additionally, the annual sales of IAQ products and services are valued at $18–$30 billion and are associated with approximately 150,000–250,000 current jobs in the US.

The goal of the EPA’s Indoor Environmental Division is to reduce the environmental health risks posed by contaminants in indoor environments. This is achieved by understanding the science of both environmental health risks and effective prevention and control methods. This knowledge then is used to promote appropriate, evidence-based environmental risk reduction activities through voluntary actions by the general public and key stakeholders to improve IAQ.

The EPA is soliciting applications from eligible entities (as described in Section III.A) to conduct demonstration, technical assistance, training, education, and/or outreach projects that seek to reduce exposure to indoor air contaminants by advancing national policy and systems-level initiatives.